Sandra Rajme‐López

ORCID: 0000-0001-7809-9619
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Long-Term Effects of COVID-19
  • COVID-19 and healthcare impacts
  • Antibiotic Use and Resistance
  • Antifungal resistance and susceptibility
  • Fungal Infections and Studies
  • Bacterial Identification and Susceptibility Testing
  • Infection Control and Ventilation
  • Immunodeficiency and Autoimmune Disorders
  • Vaccine Coverage and Hesitancy
  • Nosocomial Infections in ICU
  • Respiratory Support and Mechanisms
  • Blood disorders and treatments
  • COVID-19 Impact on Reproduction
  • Public Health and Environmental Issues
  • Artificial Intelligence in Healthcare and Education
  • COVID-19 diagnosis using AI
  • COVID-19 and Mental Health
  • Clinical Reasoning and Diagnostic Skills
  • Diabetes and associated disorders
  • Antibiotic Resistance in Bacteria
  • SARS-CoV-2 detection and testing
  • Hematological disorders and diagnostics
  • T-cell and B-cell Immunology

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
2014-2025

Office of Infectious Diseases
2021

Cameron R. Wolfe Kay M Tomashek Thomas F. Patterson Carlos A. Gómez Vincent C. Marconi and 95 more Mamta K. Jain Otto O. Yang Catharine I. Paules Guillermo M. Ruiz Palacios Robert Grossberg Michelle Harkins Richard A. Mularski Nathaniel Erdmann Uriel Sandkovsky Eyad Almasri Justino Regalado Pineda Alexandra W. Dretler Diego López de Castilla Angela R. Branche Pauline K. Park Aneesh K. Mehta William R. Short Susan McLellan Susan Kline Nicole M. Iovine Hana M. El Sahly Sarah B. Doernberg Myoung‐don Oh Nikhil Huprikar Elizabeth Hohmann Colleen F. Kelley Mark Holodniy Eu Suk Kim Daniel A. Sweeney Robert W. Finberg Kevin A. Grimes Ryan C. Maves Emily R. Ko John J. Engemann Barbara S. Taylor Philip O. Ponce LuAnn Larson Dante P. Melendez Allan Seibert Nadine Rouphael Joslyn K. Strebe Jesse L. Clark Kathleen G. Julian Alfredo Ponce‐de‐León Anabela Cardoso Stephanie de Bono Robert L. Atmar Anuradha Ganesan Jennifer L Ferreira Michelle Green Mat Makowski Tyler Bonnett Tatiana Beresnev Varduhi Ghazaryan Walla Dempsey Seema Nayak Lori E. Dodd John H. Beigel André C. Kalil Lana Wahid Emmanuel B. Walter Akhila G. Belur Grace R. Dreyer Jan E. Patterson Jason E. Bowling Danielle O. Dixon Angela Hewlett Robert Odrobina Jakrapun Pupaibool Satish Mocherla Suzana Lazarte Meilani Cayabyab Rezhan H. Hussein Reshma Golamari Kaleigh L. Krill Sandra Rajme‐López Paul Riska Barry S. Zingman Grégory Mertz Néstor Sosa Paul Goepfert Mezgebe Berhe Emma Dishner Mohamed Fayed Kinsley Hubel José Arturo Martinez-Orozco Nora Bautista Felix Sammy T. Elmor Amer Ryan Bechnak Youssef Saklawi Jason W. Van Winkle Diego F. Zea Maryrose Laguio‐Vila Edward E. Walsh Ann R. Falsey

10.1016/s2213-2600(22)00088-1 article EN The Lancet Respiratory Medicine 2022-05-23
André C. Kalil Aneesh K. Mehta Thomas F. Patterson Nathaniel Erdmann Carlos A. Gómez and 95 more Mamta K. Jain Cameron R. Wolfe Guillermo M. Ruiz‐Palacios Susan Kline Justino Regalado Pineda Anne F. Luetkemeyer Michelle Harkins Patrick E. H. Jackson Nicole M. Iovine Victor F. Tapson Myoung‐don Oh Jennifer A. Whitaker Richard A. Mularski Catharine I. Paules Dilek İnce Jin Takasaki Daniel A. Sweeney Uriel Sandkovsky David Wyles Elizabeth Hohmann Kevin A. Grimes Robert Grossberg Maryrose Laguio‐Vila Allison Lambert Diego López de Castilla EuSuk Kim LuAnn Larson Claire Ramsay Wan Jessica Traenkner Philip O. Ponce Jan E. Patterson Paul Goepfert Theresa A. Sofarelli Satish Mocherla Emily R. Ko Alfredo Ponce‐de‐León Sarah B. Doernberg Robert L. Atmar Ryan C. Maves Fernando Dangond Jennifer Ferreira Michelle Green Mat Makowski Tyler Bonnett Tatiana Beresnev Varduhi Ghazaryan Walla Dempsey Seema Nayak Lori E. Dodd Kay M. Tomashek John H. Beigel Angela Hewlett Barbara S. Taylor Jason E. Bowling Ruth C. Serrano Nadine Rouphael Zanthia Wiley Varun K. Phadke Laura Certain Hannah Imlay John J. Engemann Emmanuel B. Walter Jessica Meisner Sandra Rajme‐López Joanne Billings Hyun Kim José Arturo Martinez-Orozco Nora Bautista Felix Sammy T. Elmor Laurel Bristow Grégory Mertz Néstor Sosa Taison D. Bell M. West Marie‐Carmelle Elie‐Turenne Jonathan Grein Fayyaz S. Sutterwala Pyoeng Gyun Choe Chang Kyung Kang Hana M. El Sahly Kevin S. Rhie Rezhan H. Hussein Patricia Winokur Ayako Mikami Sho Saito Constance A. Benson Kimberly McConnell Mezgebe Berhe Emma Dishner Maria G. Frank Ellen Sarcone Pierre-Cedric B. Crouch Hannah Jang Nikolaus Jilg Katherine K Perez

10.1016/s2213-2600(21)00384-2 article EN publisher-specific-oa The Lancet Respiratory Medicine 2021-10-19

Background: Regional information regarding the characteristics of patients with coronavirus disease (COVID)-19 is needed for a better understanding pandemic.Objective: The objective study to describe clinical features COVID-19 diagnosed in tertiary-care center Mexico City and assess differences according treatment setting (ambulatory vs. hospital) need intensive care (IC).Methods: We conducted prospective cohort, including consecutive

10.24875/ric.20000211 article EN other-oa Revista de investigaci�n Cl�nica 2020-06-16

Objective: To describe empirical antimicrobial prescription on admission in patients with severe COVID-19, the prevalence of Hospital-Acquired Infections, and susceptibility patterns causing organisms. Methods: In this prospective cohort study a tertiary care center Mexico City, we included consecutive admitted COVID-19 between March 20th June 10th evaluated occurrence HAI. Results: 794 were during period. Empiric antibiotic treatment was started 92% (731/794); most frequent regimes...

10.3390/antibiotics10020182 article EN cc-by Antibiotics 2021-02-11

Abstract Background Early treatment of coronavirus disease 2019 (COVID-19) with remdesivir in high-risk patients, including those immunosuppression different causes, has not been evaluated. The objective this study was to assess the clinical effectiveness early among patients mild moderate COVID-19 at high risk progression. Methods This prospective cohort comparative conducted a tertiary referral center Mexico City. Patients for progression were treated an ambulatory 3-day course remdesivir....

10.1093/ofid/ofac502 article EN cc-by-nc-nd Open Forum Infectious Diseases 2022-10-01

•Clostridioides difficile infection (CDI) is widespread in hospitals.•An important rate reduction CDI was noticed a COVID-19 hospital.•Better adherence to hand hygiene and contact precautions noticed. Healthcare facility-onset Clostridioides rates substantially dropped Mexican hospital after its conversion full setting, despite heavy contamination of the environment previous year. Better may help explain this finding. most frequent healthcare-associated United States.1Magill SS Edwards JR...

10.1016/j.ajic.2020.12.008 article EN other-oa American Journal of Infection Control 2020-12-19

10.1016/j.lana.2023.100672 article EN cc-by-nc-nd The Lancet Regional Health - Americas 2024-01-01

Antimicrobial resistance is a global threat to public health. Chat Generative Pre-trained Transformer (ChatGPT®) language model tool based on artificial intelligence. ChatGPT® could analyze data from antimicrobial susceptibility tests in real time, especially places where infectious diseases (ID) specialists are not available. We aimed evaluate the agreement between and ID regarding appropriate antibiotic prescription simulated cases. Using microbiological isolates recovered our center, we...

10.1186/s12879-024-10426-9 article EN cc-by-nc-nd BMC Infectious Diseases 2025-01-07

Abstract Background Limited information exists regarding the natural history of SARS-CoV-2 infection in infants, including proportion asymptomatic disease. Moreover, impact repeated infections on immunity and clinical presentation is unknown. The possibility non-severe symptoms related to viral variants has not been explored. Incidence rate first subsequent infections. Methods This meticulous prospective cohort study, conducted from January 1st 2022 March 30th 2024, followed healthy newborns...

10.1093/ofid/ofae631.2103 article EN cc-by Open Forum Infectious Diseases 2025-01-29

Background: First-line treatments for methicillin-susceptible S. aureus (MSSA) bacteraemia are nafcillin, oxacillin, or cefazolin. Regional shortages of these antibiotics force clinicians to use other options like dicloxacillin and cephalotin. This study aims describe compare the safety efficacy cephalotin treatment MSSA bacteraemia. Methods: retrospective was conducted in a referral centre Mexico City. We identified isolates blood cultures from 1 January 2012 31 December 2022. Patients ≥ 18...

10.3390/antibiotics13020176 article EN cc-by Antibiotics 2024-02-10

Background: Even though worldwide death rates from coronavirus disease 2019 (COVID-19) have decreased, the threat of progression and for high-risk groups continues. Few direct comparisons between available severe acute respiratory syndrome 2 (SARS-CoV-2) antivirals been made. Objective: We aimed to compare two SARS-CoV-2 (nirmatrelvir/ritonavir remdesivir) against all-cause hospitalization or death. Design: This is a propensity score-matched cohort study. Methods: included all outpatients...

10.1177/20499361241236582 article EN cc-by-nc Therapeutic Advances in Infectious Disease 2024-01-01

Dexamethasone implementation for COVID-19 management represented a milestone but data regarding its impact and safety have not been consistently reproduced. We aimed to evaluate in-hospital mortality before after the of corticosteroid treatment (CS-T) severe critical COVID-19. conducted cohort study that included patients admitted with The primary outcome was death during hospitalization. Secondary outcomes length stay (LOS), need invasive mechanical ventilation (IMV), time IMV initiation,...

10.1080/22221751.2021.2011619 article EN cc-by Emerging Microbes & Infections 2021-11-29

Relatively low SARS-CoV-2 reinfection rates have been reported in vaccinated individuals, but updates considering the Omicron variant are lacking.The objective of study was to provide a current estimate rate highly immunized population.A prospective cohort Mexican hospital workers followed (March 2020-February 2022). Reinfection defined as occurrence two or more episodes COVID-19 separated by period ≥ 90 days without symptoms. The calculated number per 100,000 persons day.A total 3732...

10.24875/ric.22000159 article EN cc-by-nc-nd Revista de investigaci�n Cl�nica 2022-09-02

T cells from systemic lupus erythematosus (SLE) patients display a wide array of anomalies in peripheral immune tolerance mechanisms. The role ubiquitin ligases such as Cbl-b has been described recently these phenomena. However, its resistance to suppression phenotype SLE not characterized, which was the aim present study. Thirty (20 with active disease and 10 complete remission) 30 age- sex-matched healthy controls were recruited. Effector (CD4+ CD25- ) regulatory CD25+ (Tregs purified...

10.1111/cei.13054 article EN Clinical & Experimental Immunology 2017-09-23

Recognition of risk factors for hospital-acquired infections (HAI) in patients with COVID-19 is warranted. We aimed to describe associated the development HAI severe COVID-19. conducted a retrospective cohort study including all adult admitted between March 2020 and November 2020. The primary outcome was development. Bivariate multiple logistic regression models were constructed. Among 1540 patients, occurred 221 (14%). A total 299 episodes registered. most common...

10.3390/antibiotics12071108 article EN cc-by Antibiotics 2023-06-27

Infections caused by carbapenem-resistant Gram-negative bacteria (CR-GNB) are a significant cause of mortality and represent serious challenge to health systems. The early identification predictors could guide appropriate treatment follow-up. We aimed identify the factors associated with 90-day all-cause in patients CR-GNB infections.We conducted cohort study from 1 January 2019 30 April 2022. primary outcome was death any during first 90 days after date CR-GNB-positive culture. Secondary...

10.3390/antibiotics12071130 article EN cc-by Antibiotics 2023-06-29

Healthcare workers (HCWs) not fulfilling the coronavirus disease 2019 (COVID-19) case definition underwent severe acute respiratory virus 2 (SARS-CoV-2) screening. Risk of exposure, adherence to personal protective equipment (PPE), and symptoms were assessed. In total, 2,000 HCWs screened: 5.5% positive for SARS-CoV-2 by polymerase chain reaction (PCR). There no differences in PPE use between SARS-CoV-2-positive -negative (adherence, >90%). Nursing kitchen staff independently associated with results.

10.1017/ice.2021.68 article EN cc-by Infection Control and Hospital Epidemiology 2021-02-24

Immunocompromised patients are at risk of opportunistic infections. This is a 67-year-old woman with systemic sclerosis and knee osteoarthritis who underwent left total arthroplasty in 2009. In 2018 she surgery for presumed aseptic loosening. Inflammation purulent fluid were found; implant was removed replaced static spacer. Three weeks later, H. capsulatum isolated. She successfully treated itraconazole 18 months; cultures on revision spacer replacement negative.

10.1016/j.mmcr.2023.03.003 article EN cc-by-nc-nd Medical Mycology Case Reports 2023-03-21
Coming Soon ...